First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma
Open Access
- 1 December 1998
- Vol. 53 (12) , 1025-1029
- https://doi.org/10.1136/thx.53.12.1025
Abstract
BACKGROUND Early treatment with inhaled corticosteroids appears to improve clinical symptoms in asthma. Whether a first treatment initiated in the year following the recognition of asthma can prevent major outcomes such as admission to hospital has yet to be studied. METHODS A case-control study nested within a cohort of 13 563 newly treated asthmatic subjects selected from the databases of Saskatchewan Health (1977–1993) was undertaken to investigate the effectiveness of a first treatment with inhaled corticosteroids in preventing admissions to hospital for asthma. Study subjects were aged between five and 44 years at cohort entry. First time users of inhaled corticosteroids were compared with first time users of theophylline for a maximum of 12 months of treatment. The two treatments under study were further classified into initial and subsequent therapy to minimise selection bias and confounding by indication. Odds ratios associated with hospital admissions for asthma were estimated using conditional logistic regression. Markers of asthma severity, as well as age and sex, were considered as potential confounders. RESULTS Three hundred and three patients admitted to hospital with asthma were identified and 2636 matched controls were selected. Subjects initially treated with regular inhaled corticosteroids were 40% less likely to be admitted to hospital for asthma than regular users of theophylline (odds ratio 0.6; 95% CI 0.4 to 1.0). The odds ratio decreased to 0.2 (95% CI 0.1 to 0.5) when inhaled corticosteroids and theophylline were given subsequently. CONCLUSION The first regular treatment with inhaled corticosteroids initiated in the year following the recognition of asthma can reduce the risk of admission to hospital for asthma by up to 80% compared with regular treatment with theophylline. This is probably due, at least in part, to reducing the likelihood of a worsening in the severity of asthma.Keywords
This publication has 26 references indexed in Scilit:
- Inhaled Glucocorticoids for AsthmaNew England Journal of Medicine, 1995
- Inhaled Budesonide for Mild AsthmaNew England Journal of Medicine, 1995
- Treating Mild Asthma -- When Are Inhaled Steroids Indicated?New England Journal of Medicine, 1994
- Effects of Reducing or Discontinuing Inhaled Budesonide in Patients with Mild AsthmaNew England Journal of Medicine, 1994
- Guidelines on the management of asthma. Statement by the British Thoracic Society, the Brit. Paediatric Association, the Research Unit of the Royal College of Physicians of London, the King's Fund Centre, the National Asthma Campaign, the Royal College of General Practitioners, the General Practitioners in Asthma Group, the Brit. Assoc. of Accident and Emergency Medicine, and the Brit. Paediatric Respiratory Group.Thorax, 1993
- Markers of Risk of Asthma Death or Readmission in the 12 Months Following a Hospital Admission for AsthmaInternational Journal of Epidemiology, 1992
- A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trialJournal of Allergy and Clinical Immunology, 1992
- Comparison of a β2-Agonist, Terbutaline, with an Inhaled Corticosteroid, Budesonide, in Newly Detected AsthmaNew England Journal of Medicine, 1991
- A case-control study of deaths from asthma.Thorax, 1986
- Can postmarketing surveillance help to effect optimal drug therapy?JAMA, 1979